Peptide-targeted polyglutamic acid doxorubicin conjugates for the treatment of alpha(v)beta(6)-positive cancers.
Peptide-targeted polyglutamic acid doxorubicin conjugates for the treatment of alpha(v)beta(6)-positive cancers.
复制标题
DOI:
10.1021/bc800154f
复制
发表时间:
2008-09
影响因子:
4.7
通讯作者:
Brown KC
中科院分区:
文献类型:
--
作者:
Guan H;McGuire MJ;Li S;Brown KC
Most chemotherapeutics exert their effects on tumor cells as well as their healthy counterparts, resulting in dose limiting side effects. Cell-specific delivery of therapeutics can increase the therapeutic window for treatment by maintaining the therapeutic efficacy while decreasing the untoward side effects. We have previously identified a peptide, named H2009.1, which binds to the integrin αvβ6. Here, we report the synthesis of a peptide targeted polyglutamic acid polymer in which the high affinity αvβ6-specific tetrameric H2009.1 peptide is incorporated via a thioether at the N-terminus of a 15 amino acid polymer of glutamic acid. Doxorubicin is incorporated into the polymer via an acid-labile hydrazone bond. Payloads of four doxorubicin molecules per targeting agent are achieved. The drug is released at pH 4.0 and 5.6 but the conjugate is stable at pH 7.0. The conjugate is selectively internalized into αvβ6 positive cells as witnessed by flow cytometric analysis and fluorescent microscopy. Cellular uptake is mediated by the H2009.1 peptide, as no internalization of the doxorubicin-PG polymer is observed when it is conjugated to a scrambled sequence control peptide. Importantly, the conjugate is more cytotoxic toward a targeted cell than a cell line that does not express the integrin.
登录
查看更多内容
影响因子:
2.8
作者:
Kawashima, A;Tsugawa, S;Oda, Y
通讯作者:
Oda, Y
影响因子:
4.7
作者:
Dubowchik, GM;Firestone, RA;Trail, PA
通讯作者:
Trail, PA
影响因子:
3.2
作者:
Ahmed, N;Riley, C;Baker, MS
通讯作者:
Baker, MS
影响因子:
10.8
作者:
Kovár, M;Mrkvan, T;Ríhová, B
通讯作者:
Ríhová, B
影响因子:
11.2
作者:
Elayadi, Anissa N.;Samli, Kausar N.;Brown, Kathlynn C.
通讯作者:
Brown, Kathlynn C.